Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 2. fázisNot yet taking people in KínaA Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(Phase II Study Ongoing)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 90
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT07609251 - 2. fázisTaking peopleA ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy
- Where
- Guangzhou, Meizhou, Shantou, Shenzhen
- Életkor
- 18 év and over
- People
- 120
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT07375316 - 1/2. fázisTaking peopleA Study of JMT203 in Patients With Cancer Cachexia
- Where
- Zhejiang
- Életkor
- 18 év and over
- People
- 307
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT06868849 - No phaseTaking peopleProspective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 65
- Run by
- Guangzhou Concord Cancer Center
See details and how to joinNCT07412327 - 3. fázisNot yet taking people in KínaA Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 450
- Run by
- Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07601048 - 3. fázisTaking peoplePhase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Linyi, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Tianjin, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00 - No phaseNot yet taking people in KínaApplication of Electromagnetic Navigation System in Pulmonary Nodule Localization
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 400
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07595120 - 2. fázisTaking peopleSerplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%
- Where
- Xi'an
- Életkor
- 65 év and over
- People
- 60
- Run by
- Tang-Du Hospital
See details and how to joinNCT07596121 - No phaseNot yet taking people in KínaAnalysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
- Where
- Beijing, Shenzhen, Taiyuan
- Életkor
- 1 év and over
- People
- 300
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07596524 - 2. fázisTaking peoplePhase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 78
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06868836 - 1. fázisNot yet taking people in KínaA Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Beijing DCTY Biotech Co.,Ltd.
See details and how to joinNCT07014878 - 2. fázisTaking peopleA Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 864
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT07309276 - No phaseNot yet taking people in KínaPreoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 200
- Run by
- Sichuan Cancer Hospital and Research Institute
See details and how to joinNCT07590596 - 1/2. fázisTaking peopleFirst-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 105
- Run by
- Gang Hou
See details and how to joinNCT07332858 - No phaseTaking peopleMultimodal AI-Guided Recovery Management After Lung Cancer Surgery
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 868
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07588737 - No phaseNot yet taking people in Kína5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07589101 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - 2. fázisTaking peopleRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 220
- Run by
- Peking University People's Hospital
See details and how to joinNCT07586826 - No phaseTaking peopleClinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
- Where
- Shanghai
- Életkor
- 18 év to 74 év
- People
- 367
- Run by
- Shanghai University of Traditional Chinese Medicine
See details and how to joinNCT05834413 - 3. fázisTaking peopleNeoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 478
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06437977 - 2. fázisTaking peopleA Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer
- Where
- Chengdu, Guangzhou, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT07444437 - 2. fázisTaking peopleA Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07489716 - 1. fázisNot yet taking people in KínaA Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 192
- Run by
- Corregene Biotechnology Co., Ltd
See details and how to joinNCT07583316 - 2. fázisTaking peopleTeniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 90
- Run by
- Sun Yat-sen University
See details and how to joinNCT07583511